A detailed history of Darwin Advisors, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Darwin Advisors, LLC holds 25 shares of DXCM stock, worth $2,005. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25
Holding current value
$2,005
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$64.0 - $116.06 $1,600 - $2,901
25 New
25 $1,000
Q3 2020

Oct 16, 2020

SELL
$95.51 - $112.95 $750,135 - $887,109
-7,854 Closed
0 $0
Q2 2020

Aug 06, 2020

BUY
$62.68 - $105.34 $484,140 - $813,646
7,724 Added 5941.54%
7,854 $3.18 Million
Q1 2020

May 01, 2020

BUY
$47.79 - $75.63 $6,212 - $9,831
130 New
130 $35,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Darwin Advisors, LLC Portfolio

Follow Darwin Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Darwin Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Darwin Advisors, LLC with notifications on news.